C Meichsner

528 total citations
12 papers, 457 citations indexed

About

C Meichsner is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, C Meichsner has authored 12 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Virology and 3 papers in Organic Chemistry. Recurrent topics in C Meichsner's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (2 papers). C Meichsner is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (2 papers). C Meichsner collaborates with scholars based in Germany, Slovakia and United States. C Meichsner's co-authors include Arno Paessens, J P Kleim, Manfred Rösner, R. Bender, G Riess, Irvin Winkler, Helga Rübsamen‐Waigmann, Reinhard Kirsch, Hagen von Briesen and L. Biesert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

C Meichsner

12 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Meichsner Germany 10 289 286 151 100 72 12 457
J P Kleim Germany 12 280 1.0× 279 1.0× 123 0.8× 71 0.7× 120 1.7× 14 462
Imma Clotet‐Codina Spain 15 270 0.9× 271 0.9× 234 1.5× 147 1.5× 107 1.5× 21 539
Kelly Huber United States 9 220 0.8× 252 0.9× 63 0.4× 180 1.8× 55 0.8× 13 428
Kenji Kitano Japan 11 425 1.5× 232 0.8× 264 1.7× 279 2.8× 122 1.7× 16 609
T K Sawyer United States 9 410 1.4× 388 1.4× 89 0.6× 178 1.8× 63 0.9× 9 583
S.L. Irving United Kingdom 7 186 0.6× 218 0.8× 152 1.0× 326 3.3× 43 0.6× 8 547
C K Shih United States 6 459 1.6× 454 1.6× 41 0.3× 245 2.5× 93 1.3× 8 645
Pin-Fang Lin United States 9 221 0.8× 215 0.8× 56 0.4× 80 0.8× 23 0.3× 9 329
Beata Nowicka-Sans United States 11 307 1.1× 297 1.0× 53 0.4× 86 0.9× 72 1.0× 11 423
Shizuko Aoki United States 8 321 1.1× 170 0.6× 105 0.7× 193 1.9× 172 2.4× 9 511

Countries citing papers authored by C Meichsner

Since Specialization
Citations

This map shows the geographic impact of C Meichsner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Meichsner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Meichsner more than expected).

Fields of papers citing papers by C Meichsner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Meichsner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Meichsner. The network helps show where C Meichsner may publish in the future.

Co-authorship network of co-authors of C Meichsner

This figure shows the co-authorship network connecting the top 25 collaborators of C Meichsner. A scholar is included among the top collaborators of C Meichsner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Meichsner. C Meichsner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Budt, Karl‐Heinz, Anusch Peyman, Jochen Knolle, et al.. (1995). HIV protease inhibitor HOE/BAY 793, structure-activity relationships in a series of C2-symmetric diols. Bioorganic & Medicinal Chemistry. 3(5). 559–571. 16 indexed citations
2.
Kleim, J P, R. Bender, Reinhard Kirsch, et al.. (1995). Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication. Antimicrobial Agents and Chemotherapy. 39(10). 2253–2257. 77 indexed citations
3.
Kirsch, Reinhard, et al.. (1994). Mutational Analysis of Residue 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Virology. 200(2). 696–701. 41 indexed citations
4.
Balzarini, Jan, Anna Karlsson, C Meichsner, et al.. (1994). Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720. Journal of Virology. 68(12). 7986–7992. 41 indexed citations
5.
Peyman, Anusch, et al.. (1994). Inhibition of human immunodeficiency virus-1 protease by a C2-symmetrical phosphinic acid amide. Bioorganic & Medicinal Chemistry Letters. 4(10). 1191–1194. 8 indexed citations
6.
Kleim, J P, R. Bender, C Meichsner, et al.. (1993). Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication. Antimicrobial Agents and Chemotherapy. 37(8). 1659–1664. 107 indexed citations
7.
Müller, A., et al.. (1992). Preparation of carbocyclic phosphonate nucleosides. Tetrahedron Letters. 33(37). 5335–5338. 20 indexed citations
8.
Schramm, Hans J., Gerhard Breipohl, Stephan Henke, et al.. (1992). Inhibition of HIV-1 protease by short peptides derived from the terminal segments of the protease. Biochemical and Biophysical Research Communications. 184(2). 980–985. 11 indexed citations
9.
Briesen, Hagen von, et al.. (1990). Infection of monocytes/macrophages by HIV in vitro. Research in Virology. 141(2). 225–231. 39 indexed citations
10.
Briesen, Hagen von, et al.. (1990). The polysulphated polyxylan Hoe/Bay-946 inhibits HIV replication on human monocytes/macrophages. Research in Virology. 141(2). 251–257. 5 indexed citations
11.
12.
Biesert, L., Irvin Winkler, C Meichsner, et al.. (1988). Inhibition of HIV and virus replication by polysulphated polyxylan. AIDS. 2(6). 449–458. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J P Kleim Breakdown of academic impact, for papers by Imma Clotet‐Codina Breakdown of academic impact, for papers by Kelly Huber Breakdown of academic impact, for papers by Kenji Kitano Breakdown of academic impact, for papers by T K Sawyer Breakdown of academic impact, for papers by S.L. Irving Breakdown of academic impact, for papers by C K Shih Breakdown of academic impact, for papers by Pin-Fang Lin Breakdown of academic impact, for papers by Beata Nowicka-Sans Breakdown of academic impact, for papers by Shizuko Aoki
Rankless by CCL
2026